FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2491572170> ?p ?o ?g. }

• W2491572170 endingPage "e387" @default.
• W2491572170 startingPage "e361" @default.
• W2491572170 abstract "BackgroundTimely assessment of the burden of HIV/AIDS is essential for policy setting and programme evaluation. In this report from the Global Burden of Disease Study 2015 (GBD 2015), we provide national estimates of levels and trends of HIV/AIDS incidence, prevalence, coverage of antiretroviral therapy (ART), and mortality for 195 countries and territories from 1980 to 2015.MethodsFor countries without high-quality vital registration data, we estimated prevalence and incidence with data from antenatal care clinics and population-based seroprevalence surveys, and with assumptions by age and sex on initial CD4 distribution at infection, CD4 progression rates (probability of progression from higher to lower CD4 cell-count category), on and off antiretroviral therapy (ART) mortality, and mortality from all other causes. Our estimation strategy links the GBD 2015 assessment of all-cause mortality and estimation of incidence and prevalence so that for each draw from the uncertainty distribution all assumptions used in each step are internally consistent. We estimated incidence, prevalence, and death with GBD versions of the Estimation and Projection Package (EPP) and Spectrum software originally developed by the Joint United Nations Programme on HIV/AIDS (UNAIDS). We used an open-source version of EPP and recoded Spectrum for speed, and used updated assumptions from systematic reviews of the literature and GBD demographic data. For countries with high-quality vital registration data, we developed the cohort incidence bias adjustment model to estimate HIV incidence and prevalence largely from the number of deaths caused by HIV recorded in cause-of-death statistics. We corrected these statistics for garbage coding and HIV misclassification.FindingsGlobal HIV incidence reached its peak in 1997, at 3·3 million new infections (95% uncertainty interval [UI] 3·1–3·4 million). Annual incidence has stayed relatively constant at about 2·6 million per year (range 2·5–2·8 million) since 2005, after a period of fast decline between 1997 and 2005. The number of people living with HIV/AIDS has been steadily increasing and reached 38·8 million (95% UI 37·6–40·4 million) in 2015. At the same time, HIV/AIDS mortality has been declining at a steady pace, from a peak of 1·8 million deaths (95% UI 1·7–1·9 million) in 2005, to 1·2 million deaths (1·1–1·3 million) in 2015. We recorded substantial heterogeneity in the levels and trends of HIV/AIDS across countries. Although many countries have experienced decreases in HIV/AIDS mortality and in annual new infections, other countries have had slowdowns or increases in rates of change in annual new infections.InterpretationScale-up of ART and prevention of mother-to-child transmission has been one of the great successes of global health in the past two decades. However, in the past decade, progress in reducing new infections has been slow, development assistance for health devoted to HIV has stagnated, and resources for health in low-income countries have grown slowly. Achievement of the new ambitious goals for HIV enshrined in Sustainable Development Goal 3 and the 90-90-90 UNAIDS targets will be challenging, and will need continued efforts from governments and international agencies in the next 15 years to end AIDS by 2030.FundingBill & Melinda Gates Foundation, and National Institute of Mental Health and National Institute on Aging, National Institutes of Health. Timely assessment of the burden of HIV/AIDS is essential for policy setting and programme evaluation. In this report from the Global Burden of Disease Study 2015 (GBD 2015), we provide national estimates of levels and trends of HIV/AIDS incidence, prevalence, coverage of antiretroviral therapy (ART), and mortality for 195 countries and territories from 1980 to 2015. For countries without high-quality vital registration data, we estimated prevalence and incidence with data from antenatal care clinics and population-based seroprevalence surveys, and with assumptions by age and sex on initial CD4 distribution at infection, CD4 progression rates (probability of progression from higher to lower CD4 cell-count category), on and off antiretroviral therapy (ART) mortality, and mortality from all other causes. Our estimation strategy links the GBD 2015 assessment of all-cause mortality and estimation of incidence and prevalence so that for each draw from the uncertainty distribution all assumptions used in each step are internally consistent. We estimated incidence, prevalence, and death with GBD versions of the Estimation and Projection Package (EPP) and Spectrum software originally developed by the Joint United Nations Programme on HIV/AIDS (UNAIDS). We used an open-source version of EPP and recoded Spectrum for speed, and used updated assumptions from systematic reviews of the literature and GBD demographic data. For countries with high-quality vital registration data, we developed the cohort incidence bias adjustment model to estimate HIV incidence and prevalence largely from the number of deaths caused by HIV recorded in cause-of-death statistics. We corrected these statistics for garbage coding and HIV misclassification. Global HIV incidence reached its peak in 1997, at 3·3 million new infections (95% uncertainty interval [UI] 3·1–3·4 million). Annual incidence has stayed relatively constant at about 2·6 million per year (range 2·5–2·8 million) since 2005, after a period of fast decline between 1997 and 2005. The number of people living with HIV/AIDS has been steadily increasing and reached 38·8 million (95% UI 37·6–40·4 million) in 2015. At the same time, HIV/AIDS mortality has been declining at a steady pace, from a peak of 1·8 million deaths (95% UI 1·7–1·9 million) in 2005, to 1·2 million deaths (1·1–1·3 million) in 2015. We recorded substantial heterogeneity in the levels and trends of HIV/AIDS across countries. Although many countries have experienced decreases in HIV/AIDS mortality and in annual new infections, other countries have had slowdowns or increases in rates of change in annual new infections. Scale-up of ART and prevention of mother-to-child transmission has been one of the great successes of global health in the past two decades. However, in the past decade, progress in reducing new infections has been slow, development assistance for health devoted to HIV has stagnated, and resources for health in low-income countries have grown slowly. Achievement of the new ambitious goals for HIV enshrined in Sustainable Development Goal 3 and the 90-90-90 UNAIDS targets will be challenging, and will need continued efforts from governments and international agencies in the next 15 years to end AIDS by 2030." @default.
• W2491572170 created "2016-08-23" @default.
• W2491572170 creator A5000035635 @default.
• W2491572170 creator A5000299641 @default.
• W2491572170 creator A5000338880 @default.
• W2491572170 creator A5000535250 @default.
• W2491572170 creator A5000557894 @default.
• W2491572170 creator A5001032826 @default.
• W2491572170 creator A5001395865 @default.
• W2491572170 creator A5001539177 @default.
• W2491572170 creator A5001956429 @default.
• W2491572170 creator A5002528924 @default.
• W2491572170 creator A5002839931 @default.
• W2491572170 creator A5003051173 @default.
• W2491572170 creator A5003138186 @default.
• W2491572170 creator A5003551048 @default.
• W2491572170 creator A5004148699 @default.
• W2491572170 creator A5004216356 @default.
• W2491572170 creator A5004515522 @default.
• W2491572170 creator A5004638089 @default.
• W2491572170 creator A5005157826 @default.
• W2491572170 creator A5005327758 @default.
• W2491572170 creator A5005629692 @default.
• W2491572170 creator A5005934437 @default.
• W2491572170 creator A5006114153 @default.
• W2491572170 creator A5006158640 @default.
• W2491572170 creator A5006451914 @default.
• W2491572170 creator A5006582917 @default.
• W2491572170 creator A5006604586 @default.
• W2491572170 creator A5006705793 @default.
• W2491572170 creator A5006875478 @default.
• W2491572170 creator A5007254252 @default.
• W2491572170 creator A5007411703 @default.
• W2491572170 creator A5007444097 @default.
• W2491572170 creator A5007514083 @default.
• W2491572170 creator A5007975878 @default.
• W2491572170 creator A5008053694 @default.
• W2491572170 creator A5008502995 @default.
• W2491572170 creator A5008541186 @default.
• W2491572170 creator A5008755252 @default.
• W2491572170 creator A5008850617 @default.
• W2491572170 creator A5008919756 @default.
• W2491572170 creator A5008989080 @default.
• W2491572170 creator A5009174857 @default.
• W2491572170 creator A5009547480 @default.
• W2491572170 creator A5009989965 @default.
• W2491572170 creator A5010457765 @default.
• W2491572170 creator A5010649271 @default.
• W2491572170 creator A5010810456 @default.
• W2491572170 creator A5010928268 @default.
• W2491572170 creator A5011254399 @default.
• W2491572170 creator A5011882866 @default.
• W2491572170 creator A5011976258 @default.
• W2491572170 creator A5012100313 @default.
• W2491572170 creator A5012346339 @default.
• W2491572170 creator A5012390350 @default.
• W2491572170 creator A5012482667 @default.
• W2491572170 creator A5012744052 @default.
• W2491572170 creator A5012870549 @default.
• W2491572170 creator A5012925236 @default.
• W2491572170 creator A5013017179 @default.
• W2491572170 creator A5013092108 @default.
• W2491572170 creator A5013401152 @default.
• W2491572170 creator A5013553497 @default.
• W2491572170 creator A5013569815 @default.
• W2491572170 creator A5013732417 @default.
• W2491572170 creator A5013930705 @default.
• W2491572170 creator A5014144219 @default.
• W2491572170 creator A5014157210 @default.
• W2491572170 creator A5014251117 @default.
• W2491572170 creator A5014551715 @default.
• W2491572170 creator A5014800121 @default.
• W2491572170 creator A5015248793 @default.
• W2491572170 creator A5015302801 @default.
• W2491572170 creator A5015350570 @default.
• W2491572170 creator A5015542973 @default.
• W2491572170 creator A5016094682 @default.
• W2491572170 creator A5016131858 @default.
• W2491572170 creator A5016365192 @default.
• W2491572170 creator A5016426186 @default.
• W2491572170 creator A5016617643 @default.
• W2491572170 creator A5016745921 @default.
• W2491572170 creator A5016936793 @default.
• W2491572170 creator A5016948214 @default.
• W2491572170 creator A5016976074 @default.
• W2491572170 creator A5017852714 @default.
• W2491572170 creator A5017879318 @default.
• W2491572170 creator A5018175714 @default.
• W2491572170 creator A5018407626 @default.
• W2491572170 creator A5018410943 @default.
• W2491572170 creator A5018625454 @default.
• W2491572170 creator A5018750358 @default.
• W2491572170 creator A5018881461 @default.
• W2491572170 creator A5019030948 @default.
• W2491572170 creator A5019047474 @default.
• W2491572170 creator A5019194539 @default.
• W2491572170 creator A5019399793 @default.
• W2491572170 creator A5019420274 @default.

• next